These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 31112620)

  • 1. Apixaban Concentrations with Lower than Recommended Dosing in Older Adults with Atrial Fibrillation.
    Sukumar S; Gulilat M; Linton B; Gryn SE; Dresser GK; Alfonsi JE; Schwarz UI; Kim RB; Schwartz JB
    J Am Geriatr Soc; 2019 Sep; 67(9):1902-1906. PubMed ID: 31112620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and Pharmacological Effects of Apixaban Dose Adjustment in the ARISTOTLE Trial.
    Zeitouni M; Giczewska A; Lopes RD; Wojdyla DM; Christersson C; Siegbahn A; De Caterina R; Steg PG; Granger CB; Wallentin L; Alexander JH;
    J Am Coll Cardiol; 2020 Mar; 75(10):1145-1155. PubMed ID: 32164888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Off-Label Reduced Dose Apixaban in Older Adults With Atrial Fibrillation and Associated Outcomes.
    Campbell AM; Pae E; Lee E; Jacisin T; Price A; DeAngelo J
    Ann Pharmacother; 2024 Jun; 58(6):572-580. PubMed ID: 37712551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparisons between Oral Anticoagulants among Older Nonvalvular Atrial Fibrillation Patients.
    Deitelzweig S; Keshishian A; Li X; Kang A; Dhamane AD; Luo X; Balachander N; Rosenblatt L; Mardekian J; Pan X; Nadkarni A; Di Fusco M; Garcia Reeves AB; Yuce H; Lip GYH
    J Am Geriatr Soc; 2019 Aug; 67(8):1662-1671. PubMed ID: 31112292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and effectiveness of reduced-dose apixaban in Japanese patients with nonvalvular atrial fibrillation in clinical practice: A sub-analysis of the STANDARD study.
    Inoue H; Umeyama M; Yamada T; Hashimoto H; Komoto A; Yasaka M
    J Cardiol; 2020 Feb; 75(2):208-215. PubMed ID: 31421933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apixaban Levels in Octogenarian Patients with Non-valvular Atrial Fibrillation.
    Nissan R; Spectre G; Hershkovitz A; Green H; Shimony S; Cooper L; Nakav S; Shochat T; Grossman A; Fuchs S
    Drugs Aging; 2019 Feb; 36(2):165-177. PubMed ID: 30460518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rivaroxaban or Apixaban for Non-Valvular Atrial Fibrillation　- Efficacy and Safety of Off-Label Under-Dosing According to Plasma Concentration.
    Suwa M; Morii I; Kino M
    Circ J; 2019 Apr; 83(5):991-999. PubMed ID: 30918237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apixaban for prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation in France: The PAROS cross-sectional study of routine clinical practice.
    Falissard B; Picard F; Mahe I; Hanon O; Touzé E; Danchin N; Lamy FX; Ricci L; Steg PG
    Arch Cardiovasc Dis; 2019; 112(6-7):400-409. PubMed ID: 31014991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Adherence to Rivaroxaban Versus Apixaban Among Patients With Atrial Fibrillation.
    McHorney CA; Peterson ED; Laliberté F; Germain G; Nelson WW; Crivera C; Schein J; Lefebvre P
    Clin Ther; 2016 Nov; 38(11):2477-2488. PubMed ID: 27789043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence to Rivaroxaban, Dabigatran, and Apixaban for Stroke Prevention in Incident, Treatment-Naïve Nonvalvular Atrial Fibrillation.
    Brown JD; Shewale AR; Talbert JC
    J Manag Care Spec Pharm; 2016 Nov; 22(11):1319-1329. PubMed ID: 27783556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study on indices of apixaban anticoagulation: A single-center prospective study.
    Komiyama M; Miyazaki Y; Wada H; Iguchi M; Abe M; Ogawa H; Akao M; Yamakage H; Satoh-Asahara N; Sunagawa Y; Morimoto T; Hasegawa K
    J Pharmacol Sci; 2018 Jun; 137(2):105-109. PubMed ID: 29866521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Effectiveness and Safety of Apixaban and Vitamin K Antagonist Therapy in Patients With Nonvalvular Atrial Fibrillation Treated in Routine German Practice.
    Coleman CI; Peacock WF; Antz M
    Heart Lung Circ; 2018 Mar; 27(3):390-393. PubMed ID: 28528780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of Apixaban Prescribing Patterns for Nonvalvular Atrial Fibrillation in Hospitalized Patients.
    Gibson CM; Smith CB; Davis S; Scalese MJ
    Ann Pharmacother; 2018 Jan; 52(1):54-59. PubMed ID: 28799408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apixaban Concentrations in Routine Clinical Care of Older Adults With Nonvalvular Atrial Fibrillation.
    Thomas A; Fang MC; Kogan S; Hubbard CC; Friedman PN; Gong L; Klein TE; Nutescu EA; O'Brien TJ; Tuck M; Perera MA; Schwartz JB
    JACC Adv; 2022 Jun; 1(2):. PubMed ID: 37961076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial apixaban dosing in patients with atrial fibrillation.
    Buchholz A; Ueberham L; Gorczynska K; Dinov B; Hilbert S; Dagres N; Husser D; Hindricks G; Bollmann A
    Clin Cardiol; 2018 May; 41(5):671-676. PubMed ID: 29542830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apixaban 5 mg Twice Daily and Clinical Outcomes in Patients With Atrial Fibrillation and Advanced Age, Low Body Weight, or High Creatinine: A Secondary Analysis of a Randomized Clinical Trial.
    Alexander JH; Andersson U; Lopes RD; Hijazi Z; Hohnloser SH; Ezekowitz JA; Halvorsen S; Hanna M; Commerford P; Ruzyllo W; Huber K; Al-Khatib SM; Granger CB; Wallentin L;
    JAMA Cardiol; 2016 Sep; 1(6):673-81. PubMed ID: 27463942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Frail Patients With Nonvalvular Atrial Fibrillation.
    Martinez BK; Sood NA; Bunz TJ; Coleman CI
    J Am Heart Assoc; 2018 Apr; 7(8):. PubMed ID: 29654196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and effectiveness of apixaban in comparison to warfarin in patients with nonvalvular atrial fibrillation: a propensity-matched analysis from Japanese administrative claims data.
    Kohsaka S; Katada J; Saito K; Terayama Y
    Curr Med Res Opin; 2018 Sep; 34(9):1627-1634. PubMed ID: 29772946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Application and Pharmacodynamic Monitoring of Apixaban in a Patient with End-Stage Renal Disease Requiring Chronic Hemodialysis.
    Kufel WD; Zayac AS; Lehmann DF; Miller CD
    Pharmacotherapy; 2016 Nov; 36(11):e166-e171. PubMed ID: 27643979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of anticoagulants apixaban, dabigatran, edoxaban and rivaroxaban in elderly Japanese patients with atrial fibrillation treated in one general hospital.
    Yamazaki-Nishioka M; Kogiku M; Noda M; Endo S; Takekawa M; Kishi H; Ota M; Notsu Y; Shimizu M; Yamazaki H
    Xenobiotica; 2019 Sep; 49(9):1001-1006. PubMed ID: 30216091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.